Perrigo Company plc (NYSE:PRGO) is included among the 15 Best 52-Week Low Dividend Stocks to Invest in.
Photo by nathan dumlao on Unsplash
On November 6, Canaccord lowered its price target on Perrigo Company plc (NYSE:PRGO) to $20 from $40, while maintaining a Buy rating on the stock, as reported by The Fly. The firm noted that although Q3 results beat expectations, sales were weaker than anticipated due to soft over-the-counter (OTC) trends and lower nutrition sales, which were affected by slower-than-expected velocities and comparisons to last year’s period when infant formula sales benefited from retailers stocking up during the port strike.
For the third quarter of 2025, Perrigo Company plc (NYSE:PRGO) reported revenue of $1.04 billion, a decline of 4.06% compared to the same period last year. Operating income came in at $73 million, down from $80 million in the prior year. President and CEO Patrick Lockwood-Taylor stated that while OTC consumption was soft during the quarter, the company delivered strong in-market performance, gaining dollar, unit, and volume share in five of seven store-brand categories and expanding share in key brands, signaling that consumers continue to choose Perrigo products at the shelf.
In other news, on November 5, Perrigo Company plc (NYSE:PRGO) announced a strategic review of its infant formula business as it shifts focus toward higher-margin branded products. The company is a leading supplier of store-brand baby formula sold under retailers’ labels at lower prices than branded options. This unit has faced challenges with quality issues at manufacturing facilities, which posed contamination risks.
Perrigo Company plc (NYSE:PRGO) is a leading consumer health company with more than a century of experience delivering high-quality health and wellness solutions, primarily in North America and Europe.
While we acknowledge the potential of PRGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Extreme Dividend Stocks to Buy According to Hedge Funds and 15 Best Passive Income Stocks to Buy Right Now.
Disclosure: None.